Lifetime risk of dementia and Alzheimer's disease: The impact of mortality on risk estimates in the Framingham Study

Sudha Seshadri, Philip A. Wolf, A. Beiser, R. Au, K. McNulty, R. White, R. B. D'Agostino

Research output: Contribution to journalArticle

231 Citations (Scopus)

Abstract

We estimated the remaining lifetime risks of developing Alzheimer's disease (AD) and dementia from all causes, based on data from longitudinal population studies. The risk of developing AD during one's lifetime depends on both disease incidence and life expectancy. Conventional estimates of cumulative incidence overestimate the risk when there is a substantial probability of mortality due to competing causes. A total of 2,611 cognitively intact subjects (1,061 men, 1,550 women; mean age, 66 ± 7 years) were prospectively evaluated for the development of AD or other dementia. A modified survival analysis was used to estimate both cumulative incidence and the sex-specific remaining lifetime risk estimates for quinquennial age groups above age 65 years. Over a 20-year follow-up period, 198 subjects developed dementia (120 with AD). The remaining lifetime risk of AD or other dementia depended on sex, being higher in women, but varied little with age between 65 and 80 years. In a 65-year-old man, the remaining lifetime risk of AD was 6.3% (95% CI, 3.9 to 8.7) and the remaining lifetime risk of developing any dementing illness was 10.9% (95% CI, 8.0 to 13.8); corresponding risks for a 65-year-old woman were 12% (95% CI, 9.2 to 14.8) and 19% (95% CI, 17.2 to 22.5). The cumulative incidence between age 65 and 100 years was much higher: for AD, 25.5% in men and 28.1% in women; for dementia, 32.8% in men and 45% in women. The actual remaining lifetime risk of AD or dementia varies with age, sex, and life expectancy and is lower than the hypothetical risk estimated by a cumulative incidence in the same population.

Original languageEnglish (US)
Pages (from-to)1498-1504
Number of pages7
JournalNeurology
Volume49
Issue number6
DOIs
StatePublished - Jan 1 1997
Externally publishedYes

Fingerprint

Dementia
Alzheimer Disease
Mortality
Incidence
Life Expectancy
Survival Analysis
Population
Longitudinal Studies
Age Groups

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Lifetime risk of dementia and Alzheimer's disease : The impact of mortality on risk estimates in the Framingham Study. / Seshadri, Sudha; Wolf, Philip A.; Beiser, A.; Au, R.; McNulty, K.; White, R.; D'Agostino, R. B.

In: Neurology, Vol. 49, No. 6, 01.01.1997, p. 1498-1504.

Research output: Contribution to journalArticle

Seshadri, Sudha ; Wolf, Philip A. ; Beiser, A. ; Au, R. ; McNulty, K. ; White, R. ; D'Agostino, R. B. / Lifetime risk of dementia and Alzheimer's disease : The impact of mortality on risk estimates in the Framingham Study. In: Neurology. 1997 ; Vol. 49, No. 6. pp. 1498-1504.
@article{713d44db74ca4a9488cb960bc77a6db5,
title = "Lifetime risk of dementia and Alzheimer's disease: The impact of mortality on risk estimates in the Framingham Study",
abstract = "We estimated the remaining lifetime risks of developing Alzheimer's disease (AD) and dementia from all causes, based on data from longitudinal population studies. The risk of developing AD during one's lifetime depends on both disease incidence and life expectancy. Conventional estimates of cumulative incidence overestimate the risk when there is a substantial probability of mortality due to competing causes. A total of 2,611 cognitively intact subjects (1,061 men, 1,550 women; mean age, 66 ± 7 years) were prospectively evaluated for the development of AD or other dementia. A modified survival analysis was used to estimate both cumulative incidence and the sex-specific remaining lifetime risk estimates for quinquennial age groups above age 65 years. Over a 20-year follow-up period, 198 subjects developed dementia (120 with AD). The remaining lifetime risk of AD or other dementia depended on sex, being higher in women, but varied little with age between 65 and 80 years. In a 65-year-old man, the remaining lifetime risk of AD was 6.3{\%} (95{\%} CI, 3.9 to 8.7) and the remaining lifetime risk of developing any dementing illness was 10.9{\%} (95{\%} CI, 8.0 to 13.8); corresponding risks for a 65-year-old woman were 12{\%} (95{\%} CI, 9.2 to 14.8) and 19{\%} (95{\%} CI, 17.2 to 22.5). The cumulative incidence between age 65 and 100 years was much higher: for AD, 25.5{\%} in men and 28.1{\%} in women; for dementia, 32.8{\%} in men and 45{\%} in women. The actual remaining lifetime risk of AD or dementia varies with age, sex, and life expectancy and is lower than the hypothetical risk estimated by a cumulative incidence in the same population.",
author = "Sudha Seshadri and Wolf, {Philip A.} and A. Beiser and R. Au and K. McNulty and R. White and D'Agostino, {R. B.}",
year = "1997",
month = "1",
day = "1",
doi = "10.1212/WNL.49.6.1498",
language = "English (US)",
volume = "49",
pages = "1498--1504",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Lifetime risk of dementia and Alzheimer's disease

T2 - The impact of mortality on risk estimates in the Framingham Study

AU - Seshadri, Sudha

AU - Wolf, Philip A.

AU - Beiser, A.

AU - Au, R.

AU - McNulty, K.

AU - White, R.

AU - D'Agostino, R. B.

PY - 1997/1/1

Y1 - 1997/1/1

N2 - We estimated the remaining lifetime risks of developing Alzheimer's disease (AD) and dementia from all causes, based on data from longitudinal population studies. The risk of developing AD during one's lifetime depends on both disease incidence and life expectancy. Conventional estimates of cumulative incidence overestimate the risk when there is a substantial probability of mortality due to competing causes. A total of 2,611 cognitively intact subjects (1,061 men, 1,550 women; mean age, 66 ± 7 years) were prospectively evaluated for the development of AD or other dementia. A modified survival analysis was used to estimate both cumulative incidence and the sex-specific remaining lifetime risk estimates for quinquennial age groups above age 65 years. Over a 20-year follow-up period, 198 subjects developed dementia (120 with AD). The remaining lifetime risk of AD or other dementia depended on sex, being higher in women, but varied little with age between 65 and 80 years. In a 65-year-old man, the remaining lifetime risk of AD was 6.3% (95% CI, 3.9 to 8.7) and the remaining lifetime risk of developing any dementing illness was 10.9% (95% CI, 8.0 to 13.8); corresponding risks for a 65-year-old woman were 12% (95% CI, 9.2 to 14.8) and 19% (95% CI, 17.2 to 22.5). The cumulative incidence between age 65 and 100 years was much higher: for AD, 25.5% in men and 28.1% in women; for dementia, 32.8% in men and 45% in women. The actual remaining lifetime risk of AD or dementia varies with age, sex, and life expectancy and is lower than the hypothetical risk estimated by a cumulative incidence in the same population.

AB - We estimated the remaining lifetime risks of developing Alzheimer's disease (AD) and dementia from all causes, based on data from longitudinal population studies. The risk of developing AD during one's lifetime depends on both disease incidence and life expectancy. Conventional estimates of cumulative incidence overestimate the risk when there is a substantial probability of mortality due to competing causes. A total of 2,611 cognitively intact subjects (1,061 men, 1,550 women; mean age, 66 ± 7 years) were prospectively evaluated for the development of AD or other dementia. A modified survival analysis was used to estimate both cumulative incidence and the sex-specific remaining lifetime risk estimates for quinquennial age groups above age 65 years. Over a 20-year follow-up period, 198 subjects developed dementia (120 with AD). The remaining lifetime risk of AD or other dementia depended on sex, being higher in women, but varied little with age between 65 and 80 years. In a 65-year-old man, the remaining lifetime risk of AD was 6.3% (95% CI, 3.9 to 8.7) and the remaining lifetime risk of developing any dementing illness was 10.9% (95% CI, 8.0 to 13.8); corresponding risks for a 65-year-old woman were 12% (95% CI, 9.2 to 14.8) and 19% (95% CI, 17.2 to 22.5). The cumulative incidence between age 65 and 100 years was much higher: for AD, 25.5% in men and 28.1% in women; for dementia, 32.8% in men and 45% in women. The actual remaining lifetime risk of AD or dementia varies with age, sex, and life expectancy and is lower than the hypothetical risk estimated by a cumulative incidence in the same population.

UR - http://www.scopus.com/inward/record.url?scp=0031467629&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031467629&partnerID=8YFLogxK

U2 - 10.1212/WNL.49.6.1498

DO - 10.1212/WNL.49.6.1498

M3 - Article

C2 - 9409336

AN - SCOPUS:0031467629

VL - 49

SP - 1498

EP - 1504

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 6

ER -